Tapewire

Nasdaq · USD

GRDX

GridAI Technologies Corp.

Export transactions ↓
Tapewire entity
7534
SEC CIK
0001604191
Parsed reports
175

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 28, 2018 Filed Jan 2, 2019 22:58 UTC PurchaseCommon Stock 9,000 $1.41 $12,690.00
Disclosure

SEC source: 0001415889-19-000010 · form4-01022019_020116.xml · nonDerivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,500

Read SEC document
December 28, 2018 Filed Jan 2, 2019 18:44 UTC
Shenouda MagedDirector · CHIEF FINANCIAL OFFICER
PurchaseCommon Stock 20,000 $1.31 $26,214.00
Disclosure

SEC source: 0001415889-19-000015 · form4-01022019_030120.xml · nonDerivative · entry 1

Shenouda Maged · CIK 0001658369 · Director · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Read SEC document
December 28, 2018 Filed Jan 2, 2019 23:47 UTC
Spoor Johan M.Director · PRESIDENT AND CEO
PurchaseCommon Stock 38,583 $1.30 $49,968.84
Disclosure

SEC source: 0001415889-19-000017 · form4-01022019_030137.xml · nonDerivative · entry 1

Spoor Johan M. · CIK 0001535289 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,617

Read SEC document
December 28, 2018 Filed Jan 2, 2019 23:03 UTC GrantCommon Stock 7,500 $1.29 $9,675.00
Disclosure

SEC source: 0001415889-19-000013 · form4-01022019_030151.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,126

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.

Read SEC document
December 28, 2018 Filed Jan 2, 2019 22:55 UTC GrantCommon Stock 7,500 $1.29 $9,675.00
Disclosure

SEC source: 0001415889-19-000009 · form4-01022019_020116.xml · nonDerivative · entry 1

Riddell Alastair · CIK 0001681349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.

Read SEC document
December 28, 2018 Filed Jan 2, 2019 23:01 UTC GrantCommon Stock 7,500 $1.29 $9,675.00
Disclosure

SEC source: 0001415889-19-000012 · form4-01022019_030147.xml · nonDerivative · entry 1

Schramm Vern Lee · CIK 0001719553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.

Read SEC document
December 28, 2018 Filed Jan 7, 2019 23:49 UTC PurchaseCommon Stock 29,575 $1.18 $34,898.50
Disclosure

SEC source: 0001415889-19-000021 · form4-01072019_030157.xml · nonDerivative · entry 4

Ross Edmund Burke Jr. · CIK 0001682557 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,516,707

F1 · shares: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F1 · price: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F4 · ownership.nature: Of the aggregate number of shares purchased on December 28, 2018, EBR Ventures, LLC purchased all 29,575 shares.

Read SEC document
December 27, 2018 Filed Jan 7, 2019 23:49 UTC PurchaseCommon Stock 23,200 $1.13 $26,216.00
Disclosure

SEC source: 0001415889-19-000021 · form4-01072019_030157.xml · nonDerivative · entry 3

Ross Edmund Burke Jr. · CIK 0001682557 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,487,132

F1 · shares: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F1 · price: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F3 · ownership.nature: Of the aggregate number of shares purchased on December 27, 2018, EBR Ventures, LLC purchased all 66,122 shares.

Read SEC document
December 27, 2018 Filed Jan 7, 2019 23:49 UTC PurchaseCommon Stock 42,922 $1.18 $50,647.96
Disclosure

SEC source: 0001415889-19-000021 · form4-01072019_030157.xml · nonDerivative · entry 2

Ross Edmund Burke Jr. · CIK 0001682557 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,463,932

F1 · shares: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F1 · price: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F3 · ownership.nature: Of the aggregate number of shares purchased on December 27, 2018, EBR Ventures, LLC purchased all 66,122 shares.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 00:05 UTC GrantCommon Stock 7,500 $2.57 $19,275.00
Disclosure

SEC source: 0001415889-18-001448 · form4-10012018_051003.xml · nonDerivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,500

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 00:03 UTC GrantCommon Stock 7,500 $2.57 $19,275.00
Disclosure

SEC source: 0001415889-18-001446 · form4-10012018_051005.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,626

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.

Read SEC document
September 28, 2018 Filed Oct 1, 2018 23:59 UTC GrantCommon Stock 7,500 $2.57 $19,275.00
Disclosure

SEC source: 0001415889-18-001444 · form4-10012018_041015.xml · nonDerivative · entry 1

Schramm Vern Lee · CIK 0001719553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.

Read SEC document
September 28, 2018 Filed Oct 1, 2018 23:56 UTC GrantCommon Stock 7,500 $2.57 $19,275.00
Disclosure

SEC source: 0001415889-18-001442 · form4-10012018_041011.xml · nonDerivative · entry 1

Riddell Alastair · CIK 0001681349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.

Read SEC document
July 12, 2018 Filed Jul 16, 2018 19:20 UTC
Shenouda MagedDirector · CHIEF FINANCIAL OFFICER
GrantOptions · Derivative 100,000 $0.00 Strike: $3.04 $0.00
Disclosure

SEC source: 0001415889-18-001118 · form4-07162018_040700.xml · derivative · entry 1

Shenouda Maged · CIK 0001658369 · Director · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-06-28

F1 · derivative.exercise_date: Options with respect to 50,000 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 50,000 shares vest upon the the first CF patient doses with MS1819 anywhere in the globe.

Read SEC document
July 12, 2018 Filed Jul 17, 2018 01:08 UTC
Spoor Johan M.Director · PRESIDENT AND CEO
GrantCommon Stock 200,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-001121 · form4-07162018_060717.xml · nonDerivative · entry 1

Spoor Johan M. · CIK 0001535289 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,034

F1 · price: Represents grant of restricted stock. Shares shall vest in increments as follows: (i) 1/6 upon the acceptance of a U.S. IND for MS 1819; (ii) 1/6 upon the the first CF patient dosed with MS1819 anywhere in the globe; (iii) 1/6 upon upon enrollment of the first 30 patients in a CF trial; (iv) 1/6 on July 12, 2019; (v) 1/6 on July 12, 2020; and (vi) 1/6 on July 12, 2021.

Read SEC document
July 12, 2018 Filed Jul 18, 2018 15:57 UTC
Dupret DanielCHIEF SCIENTIFIC OFFICER
GrantOptions · Derivative 60,000 $0.00 Strike: $3.04 $0.00
Disclosure

SEC source: 0001415889-18-001122 · form4-07182018_080729.xml · derivative · entry 2

Dupret Daniel · CIK 0001680916 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2023-06-28

F2 · derivative.exercise_date: Options with respect to 30,000 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 30,000 shares vest upon the the first CF patient dosed with MS1819 anywhere in the globe.

Read SEC document
July 12, 2018 Filed Jul 18, 2018 15:57 UTC
Dupret DanielCHIEF SCIENTIFIC OFFICER
GrantCommon Stock 15,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-001122 · form4-07182018_080729.xml · nonDerivative · entry 1

Dupret Daniel · CIK 0001680916 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · price: Represents grant of restricted stock. Shares shall vest in increments as follows: 7,500 shares upon the acceptance of a U.S. IND for MS1819, and 7,500 shares upon the the first CF patient dosed with MS1819 anywhere in the globe.

Read SEC document
July 12, 2018 Filed Jul 19, 2018 13:20 UTC
Pennington JamesCHIEF MEDICAL OFFICER
GrantOptions · Derivative 75,000 $0.00 Strike: $3.04 $0.00
Disclosure

SEC source: 0001415889-18-001136 · form4-07192018_100730.xml · derivative · entry 1

Pennington James · CIK 0001668704 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2023-06-28

F1 · derivative.exercise_date: Options with respect to 37,500 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 37,500 shares vest upon the the first CF patient dosed with MS1819 anywhere in the globe.

Read SEC document
June 30, 2018 Filed Jul 16, 2018 23:18 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-001117 · form4-07162018_040706.xml · nonDerivative · entry 1

Schramm Vern Lee · CIK 0001719553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2018.

Read SEC document
June 29, 2018 Filed Jul 16, 2018 23:22 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-001119 · form4-07162018_040747.xml · nonDerivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2018.

Read SEC document
June 29, 2018 Filed Jul 16, 2018 23:23 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-001120 · form4-07162018_040701.xml · nonDerivative · entry 1

Riddell Alastair · CIK 0001681349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2018.

Read SEC document
June 29, 2018 Filed Jul 26, 2018 22:24 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-001189 · form4-07262018_030756.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334,126

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2018.

Read SEC document
May 02, 2018 Filed Jan 7, 2019 23:49 UTC PurchaseCommon Stock 20,000 $2.50 $50,000.00
Disclosure

SEC source: 0001415889-19-000021 · form4-01072019_030157.xml · nonDerivative · entry 1

Ross Edmund Burke Jr. · CIK 0001682557 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,421,010

F1 · shares: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F1 · price: Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.

F2 · ownership.nature: Of the aggregate number of shares purchased on May 2, 2018, CEDA Investments, LLC purchased all 20,000 shares.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:16 UTC GrantCommon Stock 7,500 $3.14 $23,550.00
Disclosure

SEC source: 0001415889-18-000490 · form4-04022018_010405.xml · nonDerivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2018.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:18 UTC GrantCommon Stock 7,500 $3.14 $23,550.00
Disclosure

SEC source: 0001415889-18-000494 · form4-04022018_010419.xml · nonDerivative · entry 1

Riddell Alastair · CIK 0001681349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,500

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2018.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:17 UTC GrantCommon Stock 7,500 $3.14 $23,550.00
Disclosure

SEC source: 0001415889-18-000492 · form4-04022018_010415.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,446

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2018.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:14 UTC GrantCommon Stock 7,500 $3.14 $23,550.00
Disclosure

SEC source: 0001415889-18-000488 · form4-04022018_010427.xml · nonDerivative · entry 1

Schramm Vern Lee · CIK 0001719553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · kind: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2018.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 23:13 UTC Exercise / conversionWarrants · Derivative 8,640 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-18-000068 · form4-01162018_030101.xml · derivative · entry 6

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,474

Underlying: Common Stock · 37,114 shares

Expires 2021-10-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Under the terms of the Exercise Letter, the Company reduced the exercise price of 8,640 warrants from $5.50 per share to $2.50 per share, and agreed to amend the remaining 28,474 warrants to reduce the exercise price to $3.25 per share.

F2 · shares: Under the terms of the Exercise Letter, the Company reduced the exercise price of 8,640 warrants from $5.50 per share to $2.50 per share, and agreed to amend the remaining 28,474 warrants to reduce the exercise price to $3.25 per share.

F3 · balance_after: As noted in Note 2 above, the Issuer has agreed to amend the remaining warrants to reduce the exercise price from $5.50 per share to $3.25 per share.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 23:13 UTC Exercise / conversionWarrants · Derivative 13,680 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-18-000068 · form4-01162018_030101.xml · derivative · entry 5

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,680 shares

Expires 2020-09-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On January 11, 2018, the Reporting Person exercised warrants reported herein pursuant to a warrant repricing letter by and between the Reporting Person and the Issuer (the "Exercise Letter"). Under the terms of the Exercise Letter, the Issuer reduced the exercise price of these warrants from $5.58 per share to $2.50 per share.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 23:13 UTC Exercise / conversionWarrants · Derivative 13,680 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-18-000068 · form4-01162018_030101.xml · derivative · entry 4

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Common Stock · 13,680 shares

Expires 2020-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On January 11, 2018, the Reporting Person exercised warrants reported herein pursuant to a warrant repricing letter by and between the Reporting Person and the Issuer (the "Exercise Letter"). Under the terms of the Exercise Letter, the Issuer reduced the exercise price of these warrants from $5.58 per share to $2.50 per share.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 23:13 UTC Exercise / conversionCommon Stock 13,680 $2.50 $34,200.00
Disclosure

SEC source: 0001415889-18-000068 · form4-01162018_030101.xml · nonDerivative · entry 3

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 13,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 23:13 UTC Exercise / conversionCommon Stock 13,680 $2.50 $34,200.00
Disclosure

SEC source: 0001415889-18-000068 · form4-01162018_030101.xml · nonDerivative · entry 2

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2018 Filed Jan 16, 2018 23:13 UTC Exercise / conversionCommon Stock 8,640 $2.50 $21,600.00
Disclosure

SEC source: 0001415889-18-000068 · form4-01162018_030101.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2018 Filed Jul 26, 2018 22:22 UTC Amendment Exercise / conversionWarrants · Derivative 8,640 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-18-001188 · form4a-07262018_030737.xml · derivative · entry 6

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,474

Underlying: Common Stock · 8,640 shares

Expires 2021-10-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Under the terms of the Exercise Letter, the Issuer reduced the exercise price of 8,640 warrants from $5.50 per share to $2.50 per share, and agreed to amend the remaining 28,474 warrants to reduce the exercise price to $3.25 per share.

F5 · balance_after: As noted in Note 2 above, the Issuer has agreed to amend the remaining warrants to reduce the exercise price rom $5.50 to $3.25 per share.

Read SEC document
January 11, 2018 Filed Jul 26, 2018 22:22 UTC Amendment Exercise / conversionWarrants · Derivative 13,680 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-18-001188 · form4a-07262018_030737.xml · derivative · entry 5

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,680 shares

Expires 2020-09-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: On January 11, 2018, the Reporting Person exercised warrants reported herein pursuant to a warrant repricing letter by and between the Reporting Person and Issuer (the "Exercise Letter"). Under the terms of the Exercise Letter, the Issuer reduced the exercise price of these warrants from $5.58 per share to $2.50 per share.

Read SEC document
January 11, 2018 Filed Jul 26, 2018 22:22 UTC Amendment Exercise / conversionWarrants · Derivative 13,680 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001415889-18-001188 · form4a-07262018_030737.xml · derivative · entry 4

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,680 shares

Expires 2020-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: On January 11, 2018, the Reporting Person exercised warrants reported herein pursuant to a warrant repricing letter by and between the Reporting Person and Issuer (the "Exercise Letter"). Under the terms of the Exercise Letter, the Issuer reduced the exercise price of these warrants from $5.58 per share to $2.50 per share.

F2 · shares: These shares were inadvertently reported as being held indirectly by the Reporting Person's spouse on the Reporting Person's original Form 4. However, such shares are held jointly by the Reporting Person and his spouse, and therefore have been aggregated with the Reporting Person's direct holdings. The same error was included in one Form 4 filed by the Reporting Person after his original Form 4 was filed.

Read SEC document
January 11, 2018 Filed Jul 26, 2018 22:22 UTC Amendment Exercise / conversionCommon Stock 13,680 $2.50 $34,200.00
Disclosure

SEC source: 0001415889-18-001188 · form4a-07262018_030737.xml · nonDerivative · entry 3

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,126

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: These shares were inadvertently reported as being held indirectly by the Reporting Person's spouse on the Reporting Person's original Form 4. However, such shares are held jointly by the Reporting Person and his spouse, and therefore have been aggregated with the Reporting Person's direct holdings. The same error was included in one Form 4 filed by the Reporting Person after his original Form 4 was filed.

F1 · balance_after: The 7,500 shares issued to the Reporting Person on December 20, 2017 in connection with his services on the Issuer's Board of Directors were inadvertently omitted from the Reporting Person's holdings after the reported transactions on his original Form 4, and also omitted from one Form 4 filed by the Reporting Person after his original Form 4 was filed.

Read SEC document
January 11, 2018 Filed Jul 26, 2018 22:22 UTC Amendment Exercise / conversionCommon Stock 13,680 $2.50 $34,200.00
Disclosure

SEC source: 0001415889-18-001188 · form4a-07262018_030737.xml · nonDerivative · entry 2

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The 7,500 shares issued to the Reporting Person on December 20, 2017 in connection with his services on the Issuer's Board of Directors were inadvertently omitted from the Reporting Person's holdings after the reported transactions on his original Form 4, and also omitted from one Form 4 filed by the Reporting Person after his original Form 4 was filed.

Read SEC document
January 11, 2018 Filed Jul 26, 2018 22:22 UTC Amendment Exercise / conversionCommon Stock 8,640 $2.50 $21,600.00
Disclosure

SEC source: 0001415889-18-001188 · form4a-07262018_030737.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The 7,500 shares issued to the Reporting Person on December 20, 2017 in connection with his services on the Issuer's Board of Directors were inadvertently omitted from the Reporting Person's holdings after the reported transactions on his original Form 4, and also omitted from one Form 4 filed by the Reporting Person after his original Form 4 was filed.

Read SEC document
December 20, 2017 Filed Feb 13, 2018 22:31 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-000227 · form5-02132018_020254.xml · nonDerivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2017.

Read SEC document
December 20, 2017 Filed Feb 13, 2018 22:29 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-000225 · form5-02132018_020219.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,446

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2017.

Read SEC document
December 20, 2017 Filed Feb 13, 2018 22:18 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-000221 · form5-02132018_020223.xml · nonDerivative · entry 1

Schramm Vern Lee · CIK 0001719553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2017.

Read SEC document
December 20, 2017 Filed Feb 13, 2018 22:20 UTC GrantCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-18-000223 · form5-02132018_020200.xml · nonDerivative · entry 1

Riddell Alastair · CIK 0001681349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2017.

Read SEC document
November 10, 2017 Filed Nov 14, 2017 23:20 UTC
Spoor Johan M.Director · PRESIDENT AND CEO
OtherOptions · Derivative 100,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001415889-17-001785 · form4-11142017_031107.xml · derivative · entry 3

Spoor Johan M. · CIK 0001535289 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 100,000 shares

Expires 2021-01-04

F2 · security: Represents options granted to the Reporting Person by third parties.

F3 · derivative.exercise_date: Immediately exercisable.

Read SEC document
November 10, 2017 Filed Nov 14, 2017 23:20 UTC
Spoor Johan M.Director · PRESIDENT AND CEO
OtherCommon Stock 100,000 $1.00 $100,000.00
Disclosure

SEC source: 0001415889-17-001785 · form4-11142017_031107.xml · nonDerivative · entry 1

Spoor Johan M. · CIK 0001535289 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,034

Read SEC document
October 19, 2017 Filed Oct 23, 2017 21:44 UTC GrantCommon Stock 17,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-17-001685 · form4-10232017_021008.xml · nonDerivative · entry 1

CASAMENTO CHARLES J · CIK 0001117167 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarters ending March 31, 2017, June 30, 2017, and September 30, 2017.

Read SEC document
October 19, 2017 Filed Oct 23, 2017 17:43 UTC
Shenouda MagedDirector · CHIEF FINANCIAL OFFICER
GrantCommon Stock 22,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-17-001684 · form4-10232017_021051.xml · nonDerivative · entry 1

Shenouda Maged · CIK 0001658369 · Director · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,500

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarters ending March 31, 2017, June 30, 2017, and September 30, 2017.

Read SEC document
October 19, 2017 Filed Oct 23, 2017 21:47 UTC GrantCommon Stock 22,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-17-001686 · form4-10232017_021023.xml · nonDerivative · entry 1

Riddell Alastair · CIK 0001681349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarters ending March 31, 2017, June 30, 2017, and September 30, 2017.

Read SEC document
October 19, 2017 Filed Nov 1, 2017 22:03 UTC GrantCommon Stock 22,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-17-001743 · form4-11012017_031119.xml · nonDerivative · entry 1

BORKOWSKI EDWARD · CIK 0001197542 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,626

F1 · price: Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarters ending March 31, 2017, June 30, 2017, and September 30, 2017.

F2 · balance_after: Amount includes 103,126 shares previously issued to the Reporting Person upon the automatic conversion of an outstanding note in connection with the Issuer's initial public offering in October 2016.

Read SEC document
September 25, 2017 Filed Sep 27, 2017 21:12 UTC
Shenouda MagedDirector · CHIEF FINANCIAL OFFICER
GrantOptions · Derivative 100,000 $0.00 Strike: $4.39 $0.00
Disclosure

SEC source: 0001415889-17-001573 · form4-09272017_060908.xml · derivative · entry 1

Shenouda Maged · CIK 0001658369 · Director · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-09-25

F1 · derivative.exercise_date: Options with respect to 75,000 shares vest upon the acceptance of a US IND for MS 1819, and the remaining 25,000 vest upon the Registrant's completion of a Phase IIa clinical trial for MS1819.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.